These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29054968)

  • 21. [The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].
    Tachibana M
    Yakugaku Zasshi; 2018; 138(2):143-148. PubMed ID: 29386427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-mobility group box-1 in sterile inflammation.
    Tsung A; Tohme S; Billiar TR
    J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumor angiogenesis by HMGB1 A box peptide.
    Zhang CL; Shu MG; Qi HW; Li LW
    Med Hypotheses; 2008; 70(2):343-5. PubMed ID: 17630223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of HMGB1 in cardiovascular diseases.
    Li W; Sama AE; Wang H
    Curr Opin Pharmacol; 2006 Apr; 6(2):130-5. PubMed ID: 16487750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-mobility group box-1 as an autocrine trophic factor in white matter stroke.
    Choi JY; Cui Y; Chowdhury ST; Kim BG
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4987-E4995. PubMed ID: 28584116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The self-association of HMGB1 and its possible role in the binding to DNA and cell membrane receptors.
    Anggayasti WL; Mancera RL; Bottomley S; Helmerhorst E
    FEBS Lett; 2017 Jan; 591(2):282-294. PubMed ID: 28027393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury.
    Lu H; Zhang Z; Barnie PA; Su Z
    Cytokine Growth Factor Rev; 2019 Jun; 47():74-82. PubMed ID: 31129019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke.
    Roth S; Singh V; Tiedt S; Schindler L; Huber G; Geerlof A; Antoine DJ; Anfray A; Orset C; Gauberti M; Fournier A; Holdt LM; Harris HE; Engelhardt B; Bianchi ME; Vivien D; Haffner C; Bernhagen J; Dichgans M; Liesz A
    Sci Transl Med; 2018 Mar; 10(432):. PubMed ID: 29540615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
    Musumeci D; Roviello GN; Montesarchio D
    Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation.
    Li J; Wang Z; Li J; Zhao H; Ma Q
    Transl Stroke Res; 2024 May; ():. PubMed ID: 38740617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status and future prospects in HMGB1 and receptor researches].
    Takahashi H; Nishibori M
    Nihon Rinsho; 2016 Apr; 74(4):703-11. PubMed ID: 27333763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-mobility group box 1, oxidative stress, and disease.
    Tang D; Kang R; Zeh HJ; Lotze MT
    Antioxid Redox Signal; 2011 Apr; 14(7):1315-35. PubMed ID: 20969478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From the Cover: Tetrachlorobenzoquinone Exerts Neurological Proinflammatory Activity by Promoting HMGB1 Release, Which Induces TLR4 Clustering within the Lipid Raft.
    Fu J; Shi Q; Song X; Liu Z; Wang Y; Wang Y; Song E; Song Y
    Toxicol Sci; 2016 Oct; 153(2):303-15. PubMed ID: 27413111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral HMGB1-induced hyperalgesia in mice: Redox state-dependent distinct roles of RAGE and TLR4.
    Yamasoba D; Tsubota M; Domoto R; Sekiguchi F; Nishikawa H; Liu K; Nishibori M; Ishikura H; Yamamoto T; Taga A; Kawabata A
    J Pharmacol Sci; 2016 Feb; 130(2):139-42. PubMed ID: 26883456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.
    van Beijnum JR; Nowak-Sliwinska P; van den Boezem E; Hautvast P; Buurman WA; Griffioen AW
    Oncogene; 2013 Jan; 32(3):363-74. PubMed ID: 22391561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Mobility Group Box Protein (HMGB1): A Potential Therapeutic Target for Diabetic Encephalopathy.
    Dash UK; Mazumdar D; Singh S
    Mol Neurobiol; 2024 Oct; 61(10):8188-8205. PubMed ID: 38478143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses.
    Kim TH; Ku SK; Bae JS
    Food Chem Toxicol; 2012 Mar; 50(3-4):1118-23. PubMed ID: 22178603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.